Investigating the Effect of Obesity on Eosinophil Recruitment in Human Adipose Tissue
Not Applicable
Completed
- Conditions
- ObeseHealthy
- Interventions
- Procedure: Fat Tissue Biopsy
- Registration Number
- NCT04234295
- Lead Sponsor
- Mayo Clinic
- Brief Summary
Researchers are trying to better understand the relationship between inflammation in adipose tissue (AT) and insulin resistance.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
- Adults ages 30-50 years
- Non-smokers
- Lean subjects with a BMI of 25 or less, gender specific normal body fat,
- Obese, non-diabetic subjects with a BMI between 30 and 50 and taking no medications affecting glucose metabolism or lipid metabolism
- subjects scheduled for an elective laparoscopic or laparotomy abdominal surgery
Exclusion Criteria
- Receiving corticosteroid therapy or have a history of asthma, COPD or atopic syndrome
- taking any biologic treatment for any autoimmune disorder
- Taking any leukotriene receptor antagonist acting medications (ex. Montelukast)
- smoking
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Lean, Healthy Controls Fat Tissue Biopsy Subjects with a body mass index (BMI) of 25 or less will have a fat tissue biopsy collected Obese, Non-Diabetic Fat Tissue Biopsy Subject with a BMI between 30 and 50 kg/m2 will have fat tissue biopsy collected
- Primary Outcome Measures
Name Time Method Number of eosinophils in adipose tissue baseline eosinophil number will be measured by flow cytometry in subcutaneous (superficial) adipose tissue
- Secondary Outcome Measures
Name Time Method Correlation between eosinophil content and body mass index (BMI) baseline Measured as a linear regression between BMI (defined as the weight in Kg/height in square m; kg/m2) and eosinophil number in the fat
Trial Locations
- Locations (1)
Mayo Clinic
🇺🇸Scottsdale, Arizona, United States